Vishal C. Gupta

Partner

New York

+1 212 506 3933

Email
vcard

Areas of Work

Patent, Patent Litigation, Post-Grant Proceedings, Intellectual Property

Overview

Vishal Gupta长期专注于复杂专利诉讼、咨询和知识产权交易方面的法律服务，执业领域涉及的技术种类繁多，包括制药、生物制剂、制造工艺、医疗设备和机电设备。

Vish处理全国各地联邦法院的专利诉讼案件，包括《药品价格竞争与专利期补偿法》引发的案件。他能够在诉讼的各个阶段管理团队，包括众多简易判决动议、权利要求解释（马克曼审前听证）程序、禁令、审判和联邦巡回上诉。Vish在战略咨询、尽职调查、许可、技术交易、意见、诉讼前调查以及和解协议/谈判方面也拥有丰富的经验。

最近，Vish被《IAM专利1000》评为提供 “无与伦比”服务的执业者，称赞其学识丰富“见识高于许多人”。

在法律执业之前，Vish在马萨诸塞州总医院/哈佛医学院从事制药工作并开展了心脏移植领域的研究。

New York
New Jersey
US District Court, District of New Jersey
US District Court, Southern District of New York
US District Court, Eastern District of New York
US Court of Appeals, Federal Circuit
US Patent & Trademark Office

J.D., Benjamin N. Cardozo School of Law, 2006, Dean’s Scholar
M.E., The Cooper Union, 2006, Chemical/Biomedical Engineering
B.E., The Cooper Union, 2004, Chemical Engineering

Representative Matters

接受制药公司的委托，就降低LDL胆固醇相关的抗PCSK9单克隆抗体专利进行诉讼。
接受制药公司的委托，收购单克隆抗体专利权。
接受国际制药公司的委托，代表该公司参与《药品价格竞争与专利期补偿法》诉讼，诉讼涉及用于治疗眼部感染的AzaSite®眼用配方专利。
接受国际制药公司的委托，代表该公司参与《药品价格竞争与专利期补偿法》诉讼，诉讼涉及用于治疗艾滋病毒/艾滋病的专利Atripla®和Truvada®。
接受代表国际电子公司的委托，就有关电子照相成像设备的专利提起诉讼。
接受国际制药公司的委托，代表该公司参与《药品价格竞争与专利期补偿法》诉讼，诉讼涉及Eloxatin®（结直肠癌）的化合物和制剂专利。
接受国际制药公司，就执行和解协议提起诉讼。
接受国际制药公司的委托，代表该公司参与《药品价格竞争与专利期补偿法》诉讼，诉讼涉及治疗湿疹的LocoidLipocream®专利。
接受国际制药公司，就针对各被告的药品专利达成多项和解和许可协议。
接受国际制药公司的委托，进行与药物化合物和制剂相关的公司收购。
在各种许可和技术转让协议中代表医疗设备公司。
接受数十亿美元的私募股权基金的委托，参与包括能源和博彩机在内的各行业的企业收购和出售。

Speaking Engagements

Moderator, "Section viii Carveouts and Inducement Analysis: Post Launch Considerations Following Amarin v. Hikma," ACI 21st Annual Paragraph IV Disputes, April 29-30, 2025
Panelist, "'Shall We Dance' — Weighing the Pros and Cons of Participating in the BPCIA Patent Dance," ACI's 4th Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA, October 17, 2024
Panelist, "Litigating 'Bet the Company' Disputes," 2024 South Asian Bar Association of North America Annual Conference, Toronto, Canada, July 13, 2024
Panelist, "Balancing Innovation and Competition in BioPharma: Best Practices for Avoiding the FTC's Crosshairs Within and Outside the BPCIA," ACI 15th Summit on Biosimilars & Innovator Biologics, New York, NY, June 21, 2024
Panelist, "Strategic IP Management in Hatch-Waxman Litigation: A Dialogue with Chief IP Counsel," ACI 19th Annual Paragraph IV Disputes, New York, NY, April 26, 2024
"Preparing for Biosimilar Carve Outs: Will Skinny Labelling Work for Biosimilars?" ACI 14th Summit on Biosimilars & Innovator Biologics, Boston, MA, June 27, 2023
"Amgen v. Sanofi: Understanding How the Supreme Court May Re-Shape §112," ACI 18th Annual Paragraph IV Disputes, New York, NY, April 19, 2023
"The Ethical Practice of Paragraph IV Litigation: New Developments Impacting Professional Responsibility in the Hatch-Waxman Arena," ACI 17th Annual Paragraph IV Disputes Conference, New York, NY, April 27, 2022
Program Co-Chair, ACI 2nd Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA, October 11-27, 2022
Moderator, "The Current State of the Skinny Label Regime: Press Release Language, Marketing Materials, and the Liability for Insurance Companies," ACI 13th Summit on Biosimilars & Innovator Biologics, June 28, 2022, Boston, MA
Faculty Member, “Fundamentals of Patent Litigation,” PLI, New York, 2022
"The Orange Book: Listings, De-Listings, and Other Matters of Interest," ACI Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA, October 7, 2021
Panelist, ACI 12th Summit on Biosimilars & Innovator Biologics, June 22, 2021
Panelist, ACI 15th Annual Paragraph IV Disputes, April 26, 2021
Faculty Member, “Fundamentals of Patent Litigation,” PLI, New York, 2021
Panelist, ACI 14th Annual Paragraph IV Disputes, October 6, 2020
Panelist, ACI 11th Summit on Biosimilars and Innovator Biologics, September 23, 2020
Faculty Member, "Fundamentals of Patent Litigation," PLI, New York, 2020
"The Practice of Pharmaceutical Patent Litigation: Part 1," ACI 13th Annual Paragraph IV Disputes Conference, New York, NY, April 29, 2019
"IP in Fashion and Wearable Technology," South Asian Bar Association of North America 2018 Annual Conference, New York, NY, June 28-29, 2018
"Naming and Labeling Considerations for Biosimilar Products," ACI 9th Annual Summit on Biosimilars, New York, NY, June 25-26, 2018
"A Question of Damages: Lost Profits, Reasonable Royalties and Exceptional Findings," ACI 12th Annual Paragraph IV Disputes, New York, NY, April 23-24, 2018
"Ways to Protect Patents from Litigation," Managing Intellectual Property US Patent Forum, New York, NY, March 13, 2018
New York State Bar Association's Advanced Trial Advocacy Program, Syracuse, NY, October 18, 2017
"IPR Strategies and Parallel Proceedings Master Class: Devising Strategies for IPR Best Practices and Navigating Dual Forums in Hatch-Waxman Litigation," ACI 11th Annual Paragraph IV Disputes, New York, NY, April 25, 2017
"Industry Session: Intellectual Property: Patent Process," Biomedical Engineering Society, Minneapolis, MN, October 6, 2016
"Consequences from Failure to Innovate," NASA Cross Industry Innovation Summit, Houston, TX, September 21, 2016
"BPCIA Litigation: Updates & Developments in 2016," The Knowledge Group webinar, May 26, 2016
"Social Media and Its Effect on the Jury System," NYSBA Commercial and Federal Litigation Section Spring Meeting, New York, NY, May 14, 2016

News & Publications

Press Releases

September 11, 2024

Press Releases

September 6, 2024

Press Releases

June 6, 2024

Press Releases

June 6, 2024

Press Releases

July 7, 2023

Press Releases

June 1, 2023

Client Alerts

May 26, 2023

By: Joseph F. Ecker, 李志英博士, Ph.D., Vishal C. Gupta

Press Releases

February 2, 2023

Press Releases

June 30, 2022

Press Releases

June 3, 2022

View All

Noteworthy

当选纽约“超级律师”，被《知识产权诉讼》评为“新星”（2013-2018年）
《IAM专利1000》，诉讼：纽约（2016-2018年）
《国际生命科学律师名人录》，专利诉讼（2016年）

Professional Affiliations

美国知识产权法协会
纽约知识产权法协会